
Colon cancer: AI-based marker can improve quality of treatment
Usind deep learning and digital scanning of conventional hematoxylin and eosin-stained tumor tissue sections, researchers have developed a clinically useful prognostic marker.
Usind deep learning and digital scanning of conventional hematoxylin and eosin-stained tumor tissue sections, researchers have developed a clinically useful prognostic marker.
Egidijus Pelanis, a medical doctor at Oslo University Hospital, explains how extended realities is applied in the operating room.
Researchers have analysed whether better design of deep learning studies can lead to the faster transformation of medical practices.